DK1556701T3 - Fremgangsmåde til forbedret diagnose af dysplasier - Google Patents

Fremgangsmåde til forbedret diagnose af dysplasier

Info

Publication number
DK1556701T3
DK1556701T3 DK03809343.1T DK03809343T DK1556701T3 DK 1556701 T3 DK1556701 T3 DK 1556701T3 DK 03809343 T DK03809343 T DK 03809343T DK 1556701 T3 DK1556701 T3 DK 1556701T3
Authority
DK
Denmark
Prior art keywords
dysplasia
procedure
improved diagnosis
diagnosis
improved
Prior art date
Application number
DK03809343.1T
Other languages
English (en)
Inventor
Ruediger Ridder
Anja Reichert
Marcus Trunk-Gehmacher
Richard Batrla
Original Assignee
Roche Mtm Lab Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02024030A external-priority patent/EP1416278B1/en
Application filed by Roche Mtm Lab Ag filed Critical Roche Mtm Lab Ag
Application granted granted Critical
Publication of DK1556701T3 publication Critical patent/DK1556701T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK03809343.1T 2002-10-28 2003-10-21 Fremgangsmåde til forbedret diagnose af dysplasier DK1556701T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02024030A EP1416278B1 (en) 2002-10-28 2002-10-28 Method for improved diagnosis of dysplasias
EP03100584A EP1422526A1 (en) 2002-10-28 2003-03-07 Method for improved diagnosis of dysplasias
PCT/EP2003/050738 WO2004038418A1 (en) 2002-10-28 2003-10-21 Method for improved diagnosis of dysplasias

Publications (1)

Publication Number Publication Date
DK1556701T3 true DK1556701T3 (da) 2012-11-19

Family

ID=32178671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03809343.1T DK1556701T3 (da) 2002-10-28 2003-10-21 Fremgangsmåde til forbedret diagnose af dysplasier

Country Status (9)

Country Link
US (8) US20070128599A1 (da)
EP (2) EP1422526A1 (da)
JP (3) JP2006503589A (da)
AU (1) AU2003301564A1 (da)
CA (1) CA2496465C (da)
DK (1) DK1556701T3 (da)
ES (1) ES2391893T3 (da)
PL (1) PL214860B1 (da)
WO (1) WO2004038418A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
DE60200248T2 (de) 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
US8951746B2 (en) 2004-11-05 2015-02-10 Southwest Research Institute Method and devices for screening cervical cancer
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
US8131476B2 (en) 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
GB0720113D0 (en) 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
EP2356460B1 (en) * 2008-09-04 2018-01-24 Ventana Medical Systems, Inc. Method for prediction of the progression risk of tumors
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
EP2533798A2 (en) * 2010-02-09 2012-12-19 Universität Bremen P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
JP5553661B2 (ja) * 2010-03-30 2014-07-16 シスメックス株式会社 癌の再発リスク判定方法
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US9605319B2 (en) 2010-08-30 2017-03-28 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
EP2638396B1 (en) 2010-11-12 2017-03-01 incellDX, Inc. Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
WO2014078700A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
EP3143160B1 (en) 2014-05-13 2019-11-06 Myriad Genetics, Inc. Gene signatures for cancer prognosis
CN104807788B (zh) * 2014-12-18 2018-09-14 中山大学 一种用于监测血管重构现象的方法与试剂盒
EP4060344A1 (en) 2015-06-08 2022-09-21 Arquer Diagnostics Limited Methods and kits
CN107771285A (zh) 2015-06-08 2018-03-06 阿奎尔诊断有限公司 方法
WO2016207414A1 (en) 2015-06-25 2016-12-29 Universitaet Des Saarlandes Improved diagnostic method for hpv-induced cancer and precancerous lesion screening and diagnosis
CN105241698A (zh) * 2015-09-25 2016-01-13 四川农业大学 一种黄石爬鮡皮肤石蜡切片的制作方法
US10300153B2 (en) * 2015-11-30 2019-05-28 Asthra, Llc Immunological detection of altered cells
EP3396375B1 (en) * 2015-12-24 2021-08-04 Konica Minolta, Inc. Image processing device and program
CN109313196A (zh) * 2016-06-13 2019-02-05 皇家飞利浦有限公司 用于推断对象中的信号转导途径的转录因子的活性的方法
CN111448324A (zh) * 2017-10-23 2020-07-24 西澳大学 细胞分析或与细胞分析有关的改进
WO2019234176A1 (en) 2018-06-07 2019-12-12 Universitaet Des Saarlandes Novel biomarkers for carcinoma diagnosis
CN110553889A (zh) * 2019-09-18 2019-12-10 宋建华 自动染色机He染色工艺
ES3015712T3 (en) 2019-11-04 2025-05-07 Ummon Healthtech Method of, and computerized system for labeling an image of cells of a patient
CN111077302A (zh) * 2019-12-26 2020-04-28 江苏美克医学技术有限公司 一种基于葡聚糖信号放大ki67和p16INK4a检测试剂盒
EP4217746A1 (en) * 2020-09-24 2023-08-02 Cytosystems Limited Diagnosis of cancer by imaging flow cytometry
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
WO2023150578A2 (en) * 2022-02-01 2023-08-10 4D Path Inc. Systems and methods for image-based disease characterization

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
JPH087229A (ja) * 1994-06-13 1996-01-12 Sony Corp 磁気抵抗効果型磁気ヘッド
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5723313A (en) 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US6407062B1 (en) * 1995-09-27 2002-06-18 St. Jude Children's Research Hospital ARF-P19, a novel regulator of the mammalian cell cycle
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
JP2000511291A (ja) 1997-10-21 2000-08-29 キャンサー リサーチ キャンペーン テクノロジー リミティド 細胞の増殖異常の測定
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
DE19957689A1 (de) 1999-11-30 2001-06-13 Deutsches Krebsforsch Proteaseresistenter Tumorsuppressor p14(ARF)
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE10063112A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
NZ528205A (en) 2001-03-12 2006-09-29 Monogen Inc Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1387173A1 (en) * 2002-07-29 2004-02-04 MTM Laboratories AG Method for improved diagnosis of cervical lesions based on detection of INK4a gene products
US20050272038A1 (en) 2002-07-29 2005-12-08 Ruediger Ridder Compositions and methods for diagnosis and therapy of cancers
DE60200248T2 (de) 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP2356460B1 (en) 2008-09-04 2018-01-24 Ventana Medical Systems, Inc. Method for prediction of the progression risk of tumors
US8277190B2 (en) 2009-03-27 2012-10-02 General Electric Company Turbomachine rotor assembly and method

Also Published As

Publication number Publication date
JP5442884B2 (ja) 2014-03-12
JP2013150616A (ja) 2013-08-08
US20210071267A1 (en) 2021-03-11
US20090176204A1 (en) 2009-07-09
ES2391893T3 (es) 2012-11-30
EP1422526A1 (en) 2004-05-26
US9528159B2 (en) 2016-12-27
CA2496465A1 (en) 2004-05-06
PL214860B1 (pl) 2013-09-30
AU2003301564A8 (en) 2004-05-13
US20070128599A1 (en) 2007-06-07
EP1556701A1 (en) 2005-07-27
US20200017923A1 (en) 2020-01-16
US20090068675A1 (en) 2009-03-12
US20130189686A1 (en) 2013-07-25
US8975036B2 (en) 2015-03-10
CA2496465C (en) 2010-08-17
WO2004038418A1 (en) 2004-05-06
US8367353B2 (en) 2013-02-05
PL374898A1 (pl) 2005-11-14
US20130189685A1 (en) 2013-07-25
JP2006503589A (ja) 2006-02-02
JP2009142294A (ja) 2009-07-02
US20210047697A1 (en) 2021-02-18
AU2003301564A1 (en) 2004-05-13
EP1556701B1 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
DK1556701T3 (da) Fremgangsmåde til forbedret diagnose af dysplasier
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
FI20031156A0 (fi) Liotusmenetelmä
BRPI0311233A2 (pt) diagnóstico de carcinoma hepatocelular
DE60316652D1 (de) Endoskop
DE602004026245D1 (de) Endoskop
DK1520509T3 (da) Adapter til en endoskoptangåbning
DE602004021746D1 (de) Endoskop
DK1632168T3 (da) Indretning til detektion af formen af et endoskop
DK1454058T4 (da) Fremgangsmåde til overvågning af en sensor
DK1549385T3 (da) Prøvetagerhætte
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
FR2863472B1 (fr) Endoscope
FR2847154B3 (fr) Architecture amovible de fausse-dent
DE50305758D1 (de) Mikroendoskop
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DE50100883D1 (de) Dichtung für ein Endoskop
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DE10347306B4 (de) Schirmanbindung
FR2885034B1 (fr) Systeme de maintien en temperature, perioperatoire, d'un patient
DE60234241D1 (de) Endoskopische Kapsel
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DE60306501D1 (de) Dichtungsring